Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women

NCT01573637 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
78
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fundació Sant Joan de Déu

Collaborators